
### [NCIT:C5169](http://purl.obolibrary.org/obo/NCIT_C5169)
**Label:** Breast Neuroendocrine Neoplasm

**Subclasses:** [NCIT:C40356](http://purl.obolibrary.org/obo/NCIT_C40356) (Breast Large Cell Neuroendocrine Carcinoma), [NCIT:C5170](http://purl.obolibrary.org/obo/NCIT_C5170) (Breast Carcinoid Tumor), [NCIT:C5171](http://purl.obolibrary.org/obo/NCIT_C5171) (Metastatic Breast Carcinoid Tumor), [NCIT:C6760](http://purl.obolibrary.org/obo/NCIT_C6760) (Breast Small Cell Carcinoma), [NCIT:C97965](http://purl.obolibrary.org/obo/NCIT_C97965) (Breast Solid Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C43574](http://purl.obolibrary.org/obo/NCIT_C43574) (Neuroendocrine Differentiation) 55.56%
- Thing 52.40%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 40.91%


